Cargando…
Chemoselective Covalent Modification of K-Ras(G12R) with a Small Molecule Electrophile
[Image: see text] KRAS mutations are one of the most common oncogenic drivers in human cancer. While small molecule inhibitors for the G12C mutant have been successfully developed, allele-specific inhibition for other KRAS hotspot mutants remains challenging. Here we report the discovery of covalent...
Autores principales: | Zhang, Ziyang, Morstein, Johannes, Ecker, Andrew K., Guiley, Keelan Z., Shokat, Kevan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460778/ https://www.ncbi.nlm.nih.gov/pubmed/36001446 http://dx.doi.org/10.1021/jacs.2c05377 |
Ejemplares similares
-
Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
por: Zhang, Ziyang, et al.
Publicado: (2022) -
A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability
por: Guiley, Keelan Z., et al.
Publicado: (2023) -
A covalent inhibitor of K-Ras(G12C) induces MHC-I presentation of haptenated peptide neoepitopes targetable by immunotherapy
por: Zhang, Ziyang, et al.
Publicado: (2022) -
GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D)
Block Its Interaction with Raf
por: Zhang, Ziyang, et al.
Publicado: (2020) -
Direct Modulators
of K-Ras–Membrane
Interactions
por: Morstein, Johannes, et al.
Publicado: (2023)